← The Wire
ACRSNasdaq
Aclaris Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1557746
Aclaris Therapeutics develops prescription drug products, focusing on obtaining and maintaining favorable coverage and reimbursement
$603M
Market cap
$5.02
Last close
+0.4%
1D
+3.7%
5D
1.8M
Volume
Price · last 39 sessions+10.8%
May 4L $4.10 · H $5.09Jun 29
272
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 4, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 20268-KReg FD Disclosure · Company UpdateApr 28, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-KReg FD DisclosureMar 11, 20268-KReg FD DisclosureMar 10, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KReg FD DisclosureJan 12, 20268-KReg FD Disclosure · Company UpdateJan 6, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KReg FD DisclosureOct 14, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KReg FD Disclosure · Company UpdateJul 29, 20258-KReg FD DisclosureJun 30, 20258-KExecutive Change · Bylaw AmendmentJun 5, 202510-Q10-QMay 8, 20258-KResults of Operations · Reg FD DisclosureMay 8, 2025DEFA14ADEFA14AApr 24, 2025DEF 14ADEF 14AApr 24, 202510-K10-KFeb 27, 20258-KResults of OperationsFeb 27, 20258-KReg FD DisclosureJan 13, 2025SC 13GSC 13GNov 25, 2024SC 13GSC 13GNov 22, 2024SC 13GSCHEDULE 13GNov 21, 20248-KExecutive Change · Material AgreementNov 18, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 6, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KMaterial Agreement · Reg FD DisclosureJul 16, 20248-KShareholder VoteJun 7, 202410-Q10-QMay 7, 20248-KResults of Operations · Reg FD DisclosureMay 7, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 20248-KExecutive ChangeMar 19, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 2024SC 13GSC 13GFeb 14, 2024SC 13GSCHEDULE 13GFeb 13, 20248-K/AExecutive ChangeFeb 5, 20248-KExecutive ChangeFeb 5, 20248-KExecutive Change · Results of OperationsJan 19, 2024SC 13GSC 13GJan 16, 20248-KExit / Disposal Costs · Reg FD DisclosureDec 19, 2023SC 13GSC 13GDec 11, 2023SC 13GSC 13GNov 24, 20238-KReg FD Disclosure · Company UpdateNov 13, 202310-Q10-QNov 6, 20238-KResults of OperationsNov 6, 20238-KReg FD DisclosureSep 18, 2023SC 13GSC 13GSep 5, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KExecutive ChangeJun 12, 20238-KShareholder VoteJun 2, 20238-KMaterial AgreementJun 1, 202310-Q10-QMay 8, 20238-KResults of Operations · Reg FD DisclosureMay 8, 2023DEFA14ADEFA14AApr 20, 2023DEF 14ADEF 14AApr 20, 20238-KReg FD DisclosureApr 14, 20238-KReg FD DisclosureMar 31, 20238-KExecutive ChangeMar 27, 2023SC 13GSCHEDULE 13GMar 16, 20238-KCompany UpdateMar 6, 20238-KMaterial Agreement · Agreement TerminatedFeb 23, 2023424B5424B5Feb 23, 202310-K10-KFeb 23, 20238-KResults of OperationsFeb 23, 20238-KReg FD DisclosureJan 9, 20238-KExecutive ChangeJan 6, 20238-KExecutive ChangeDec 13, 20228-KExecutive ChangeNov 22, 2022
Similar companies
Comparable business profile · signals at a glance